AAAAAA

   
Results: 1-8 |
Results: 8
SPECIES AND ORGAN DIFFERENCES IN FIRST-PASS METABOLISM OF THE ESTER PRODRUG L-751,164 IN DOGS AND MONKEYS - IN-VIVO AND IN-VITRO STUDIES
Authors: PRUEKSARITANONT T GORHAM LM ELLIS JD FERNANDEZMETZLER C DELUNA P GEHRET JR STRONG KL HOCHMAN JH ASKEW BC DUGGAN ME GILBERT JD LIN JH VYAS KP
Citation: T. Prueksaritanont et al., SPECIES AND ORGAN DIFFERENCES IN FIRST-PASS METABOLISM OF THE ESTER PRODRUG L-751,164 IN DOGS AND MONKEYS - IN-VIVO AND IN-VITRO STUDIES, Drug metabolism and disposition, 24(11), 1996, pp. 1263-1271
NONPEPTIDE GLYCOPROTEIN IIB IIIA INHIBITORS .8. ANTIPLATELET ACTIVITYAND ORAL ANTITHROMBOTIC EFFICACY OF L-734,217/
Authors: COOK JJ HOLAHAN MA LYLE EA RAMJIT DR SITKO GR STRANIERI MT STUPIENSKI RF WALLACE AA HAND EL GEHRET JR KOTHSTEIN T DRAG MD MCCORMICK GY PERKINS JJ IHLE NC DUGGAN ME HARTMAN GD GOULD RJ LYNCH JJ
Citation: Jj. Cook et al., NONPEPTIDE GLYCOPROTEIN IIB IIIA INHIBITORS .8. ANTIPLATELET ACTIVITYAND ORAL ANTITHROMBOTIC EFFICACY OF L-734,217/, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 62-73
DIFFERENTIAL EFFICACY OF THE CLASS-III AGENT MK-499 AGAINST PROGRAMMED STIMULATION-INDUCED AND ISCHEMIC-INDUCED VENTRICULAR ARRHYTHMIAS IN A CANINE MODEL OF PREVIOUS MYOCARDIAL-INFARCTION
Authors: LYNCH JJ WALLACE AA STUMP GL STUPIENSKI RF KOTHSTEIN T GEHRET JR
Citation: Jj. Lynch et al., DIFFERENTIAL EFFICACY OF THE CLASS-III AGENT MK-499 AGAINST PROGRAMMED STIMULATION-INDUCED AND ISCHEMIC-INDUCED VENTRICULAR ARRHYTHMIAS IN A CANINE MODEL OF PREVIOUS MYOCARDIAL-INFARCTION, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 671-678
CHRONIC CATHETERIZATION OF THE INTESTINES AND PORTAL-VEIN FOR ABSORPTION EXPERIMENTATION IN BEAGLE DOGS
Authors: KWEI GY GEHRET JR NOVAK LB DRAG MD GOODWIN T
Citation: Gy. Kwei et al., CHRONIC CATHETERIZATION OF THE INTESTINES AND PORTAL-VEIN FOR ABSORPTION EXPERIMENTATION IN BEAGLE DOGS, Laboratory animal science, 45(6), 1995, pp. 683-685
CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF TEDISAMIL
Authors: WALLACE AA STUPIENSKI RF BASKIN EP APPLEBY SD KOTHSTEIN T GEHRET JR KING SW REMY DC LYNCH JJ
Citation: Aa. Wallace et al., CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF TEDISAMIL, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 168-175
CHRONIC CATHETERIZATION OF THE INTESTINES AND PORTAL-VEIN FOR ORAL ABSORPTION EXPERIMENTATION IN BEAGLE DOGS
Authors: KWEI GY NOVAK LB GEHRET JR GOODWIN T
Citation: Gy. Kwei et al., CHRONIC CATHETERIZATION OF THE INTESTINES AND PORTAL-VEIN FOR ORAL ABSORPTION EXPERIMENTATION IN BEAGLE DOGS, The FASEB journal, 8(4), 1994, pp. 10000098-10000098
CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF 2 LONG-ACTING SPIROBENZOPYRAN PIPERIDINE CLASS-III AGENTS, L-702,958 AND L-706,000[MK-499]
Authors: LYNCH JJ WALLACE AA STUPIENSKI RF BASKIN EP BEARE CM APPLEBY SD SALATA JJ JURKIEWICZ NK SANGUINETTI MC STEIN RB GEHRET JR KOTHSTEIN T CLAREMON DA ELLIOTT JM BUTCHER JW REMY DC BALDWIN JJ
Citation: Jj. Lynch et al., CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF 2 LONG-ACTING SPIROBENZOPYRAN PIPERIDINE CLASS-III AGENTS, L-702,958 AND L-706,000[MK-499], The Journal of pharmacology and experimental therapeutics, 269(2), 1994, pp. 541-554
CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF 3,4-DIHYDRO-1'-[2-(BENZOFURAZAN-5-YL) AMIDOSPIRO[(2H)-1-BENZOPYRAN-2,4'-PIPERIDIN]-4-ONE HCL (L-691, 121), A NOVEL CLASS-III AGENT
Authors: LYNCH JJ WALLACE AA VANDERGAAG LH BASKIN EP BEAR CM GEHRET JR KOTHSTEIN T STUPIENSKI RF APPLEBY SD SANGUINETTI MC JURKIEWICZ NK ZINGARO GJ STEIN RB CLAREMON DA ELLIOTT JM YOUNG MB BALDWIN JJ
Citation: Jj. Lynch et al., CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF 3,4-DIHYDRO-1'-[2-(BENZOFURAZAN-5-YL) AMIDOSPIRO[(2H)-1-BENZOPYRAN-2,4'-PIPERIDIN]-4-ONE HCL (L-691, 121), A NOVEL CLASS-III AGENT, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 720-730
Risultati: 1-8 |